期刊文献+

Differential alterations of positive and negative regulators of beta catenin enhance endogenous expression and activity of beta catenin in A549 non small cell lung cancer(NSCLC)cells

原文传递
导出
摘要 Beta catenin has been well documented in previous studies to be involved in non small cell lung cancer(NSCLC).Beta catenin abundance and transcriptional activity are significantly regulated by several factors.Though it is well known that Akt and Gsk3 beta are respective positive and negative regulators of beta catenin,however,no single study has so far documented how the expression and activity of both positive as well as negative regulators play favorable role on beta catenin expression and activity in NSCLC.In this study,we compared expression and activity of beta catenin and its regulators in normal lung cell WI38 and NSCLC cell A549 by western blot,qRT-PCR and luciferase assay.We observed that beta catenin positive regulators(Akt and Hsp90)and negative regulators(Gsk3 beta and microRNA-214)have differential expression and/or activity in NSCLC cell A549.However the differentially altered statuses of both the positive and negative regulators rendered cumulative positive effect on beta catenin expression and activity in A549.Our study thus suggests that chemotherapeutic modulations of regulating factors are crucial when abrogation and/or inhibition of key oncogenic proteins are necessary for cancer chemotherapy.
出处 《Genes & Diseases》 SCIE 2016年第4期282-288,共7页 基因与疾病(英文)
基金 This work was supported by DAE,Government of India.We thank Prof.Nitai Pada Bhattacharyya,Former Professor,Saha Institute of Nuclear Physics,Kolkata-700064 for providing the empty U61 and miR-214-U61 plasmids and primers of U6 snRNA and miR-214.
  • 相关文献

参考文献1

二级参考文献21

  • 1Luigi Rossi,Federica Zoratto,Anselmo Papa,Francesca Iodice,Marina Minozzi,Luigi Frati,Silverio Tomao.Current approach in the treatment of hepatocellular carcinoma[J].World Journal of Gastrointestinal Oncology,2010,2(9):348-359. 被引量:11
  • 2Croce Carlo M.Causes and consequences of microRNA dysregulation in cancer. Nature Reviews Genetics . 2009
  • 3Lingxiang Yu,Jiabin Zhang,Xiaodong Guo,Zhiwei Li,Peirui Zhang.MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma[J]. Cancer Epidemiology . 2014
  • 4Zhengyu Xu,Tao Wang.miR-214 promotes the proliferation and invasion of osteosarcoma cells through direct suppression of LZTS1[J]. Biochemical and Biophysical Research Communications . 2014
  • 5Xiao Zhang,Shijie Hu,Xiang Zhang,Lei Wang,Xiaofang Zhang,Bo Yan,Jing Zhao,Angang Yang,Rui Zhang.MicroRNA-7 arrests cell cycle in G1 phase by directly targeting CCNE1 in human hepatocellular carcinoma cells[J]. Biochemical and Biophysical Research Communications . 2013
  • 6Floriane Pez,Ana?s Lopez,Miran Kim,Jack R. Wands,Claude Caron de Fromentel,Philippe Merle.Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs[J]. Journal of Hepatology . 2013
  • 7Fang Wang,Min Liu,Xin Li,Hua Tang.MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells[J]. FEBS Letters . 2013 (5)
  • 8Tsung-Chieh Shih,Yin-Jing Tien,Chih-Jen Wen,Ta-Sen Yeh,Ming-Chin Yu,Chia-Hao Huang,Yun-Shien Lee,Tzu-Chen Yen,Sen-Yung Hsieh.MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma[J]. Journal of Hepatology . 2012 (3)
  • 9Yi W Kong,David Ferland-McCollough,Thomas J Jackson,Martin Bushell.microRNAs in cancer management[J]. Lancet Oncology . 2012 (6)
  • 10Florie Borel,Pavlina Konstantinova,Peter L.M. Jansen.Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma[J]. Journal of Hepatology . 2012 (6)

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部